Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -226,835 | -180,908 | -14,708 | -6,524 | 7,590 |
| Depreciation Amortization | 8,462 | 6,447 | 4,364 | 2,121 | 8,278 |
| Income taxes - deferred | 23,243 | -7,684 | -3,308 | -4,465 | -5,636 |
| Accounts receivable | -859 | -2,595 | -3,318 | 7,341 | 26,618 |
| Other Working Capital | 112,267 | 113,382 | -24,834 | -13,898 | 17,957 |
| Other Operating Activity | 23,060 | 21,974 | 14,557 | -1,244 | 4,097 |
| Operating Cash Flow | $-60,662 | $-49,384 | $-27,247 | $-16,669 | $58,904 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 98,448 | 75,951 | 47,422 | 26,545 | 96,009 |
| PPE Investments | -16,661 | -13,598 | -9,013 | -1,909 | -10,614 |
| Purchase Of Investment | -132,068 | -108,503 | -72,060 | -46,510 | -115,375 |
| Sale Of Investment | 32,471 | 22,303 | 2,919 | 1,620 | 7,948 |
| Investing Cash Flow | $-17,810 | $-23,847 | $-30,732 | $-20,254 | $-22,032 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,871 | 4,386 | 3,167 | 654 | 6,083 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -16,099 |
| Other Financing Activity | -42 | -42 | 0 | 0 | -1,729 |
| Financing Cash Flow | $5,829 | $4,344 | $3,167 | $654 | $-11,745 |
| Beginning Cash Position | 104,642 | 104,642 | 104,642 | 104,642 | 79,515 |
| End Cash Position | 31,999 | 35,755 | 49,830 | 68,373 | 104,642 |
| Net Cash Flow | $-72,643 | $-68,887 | $-54,812 | $-36,269 | $25,127 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,662 | -49,384 | -27,247 | -16,669 | 58,904 |
| Capital Expenditure | -16,661 | -13,598 | -9,013 | -1,909 | -10,614 |
| Free Cash Flow | -77,323 | -62,982 | -36,260 | -18,578 | 48,290 |